Filing Details

Accession Number:
0000897069-24-000269
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-08 16:30:43
Reporting Period:
2024-02-07
Accepted Time:
2024-02-08 16:30:43
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1533743 Processa Pharmaceuticals Inc. PCSA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1378166 David Young C/O Processa Pharmaceuticals, Inc.
7380 Coca Cola Drive, Suite 106
Hanover MD 21076
Pres. Research & Development No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-07 21,000 $2.45 79,387 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 30,985 Indirect By Young-Plaisance Revocable Trust
Common Stock 10,786 Indirect By Family Entities
Common Stock 18,544 Indirect By CorLyst, LLC